Background and Purpose-Nontraumatic subarachnoid hemorrhage at the convexity of the brain (cSAH) is an incompletely characterized subtype of nonaneurysmal subarachnoid bleeding. This study sought to systematically describe the clinical presentation, etiology, and long-term outcome in patients with cSAH. Methods-For a 6-year period, we searched our radiological database for patients with nontraumatic nonaneurysmal subarachnoid hemorrhages (nϭ131) seen on CT or MRI. By subsequent image review, we identified 24 patients with cSAH defined by intrasulcal bleeding restricted to the hemispheric convexities. We reviewed their medical records, analyzed the neuroimaging studies, and followed up patients by telephone or a clinical visit. Results-The 24 patients with cSAH had a mean age of 70 years (range, 37-88 years), 20 (83%) were Ͼ60 years, and 13 (54%) were women. Patients often presented with transient sensory and/or motor symptoms (nϭ10 [42%]) and seizures (nϭ5 [21%]), whereas headaches typical of subarachnoid hemorrhage were rare (nϭ4 [17%]). MRI provided evidence for prior bleedings in 11 patients (microbleeds in 10 and parenchymal bleeds in 5) with a bleeding pattern suggestive of cerebral amyloid angiopathy in 5 subjects. At follow-up (after a mean of 33 months), 14 patients (64%) had an unfavorable outcome (modified Rankin scale score 3-6), including 5 deaths. We did not observe recurrent cSAH. Conclusions-Our data suggest that cSAH often presents with features not typical for subarachnoid bleeding. In the elderly, cSAH is frequently associated with bleeding-prone conditions such as cerebral amyloid angiopathy. Recurrence of cSAH is rare but the condition itself is a marker of poor prognosis. (Stroke. 2011;42:00-00.)
N ontraumatic subarachnoid hemorrhage (SAH) usually presents with an acute throbbing headache and is most often caused by rupture of an aneurysm. However, there exist specific sites of SAH like the perimesencephalic region where another etiology is more common. These patients usually have a normal cerebral angiogram and their bleeding is thought to be due to ruptured venous structures. As a consequence, they have a low risk of rebleeding and a normal life expectancy. 1 Another location of SAH of specific nonaneurysmal causes may be the brain's convexity. "Convexal" SAH (cSAH) is characterized by blood collections in 1 or several adjacent sulci in the absence of blood at the base of the brain or elsewhere. cSAH has been associated with various symptoms and etiologies. [2] [3] [4] [5] [6] [7] [8] [9] [10] Besides a presentation with acute throbbing headaches, which are typical for subarachnoid bleeding, a few small patient series suggested that cSAH may be a rather unexpected imaging finding when evaluating patients for transient focal sensory or motor symptoms. 5, 6 Also, several conditions have been associated with cSAH in the past. These include cortical vein thrombosis, small arteriovenous fistulae or malformations, and carotid artery occlusion or preceding revascularization procedures. [7] [8] [9] [10] From a series of 29 patients with cSAH, Kumar et al recently suggested 2 main etiologic groups. 4 Sixteen of their patients with cSAH were Յ60 years presented with a thunderclap headache and were thought to have had a reversible cerebral vasoconstriction syndrome. Patients Ͼ60 years often presented with transient focal symptoms, had no or only mild headache, and frequently showed imaging features suggestive of cerebral amyloid angiopathy (CAA).
The potential diagnostic and therapeutic implications of these observations and the absence of another large patient series prompted us to review patients with cSAH seen at our hospital, including a comprehensive analysis of clinical and imaging findings. To add prognostic information, we also obtained follow-up data wherever possible.
Methods

Study Participants
We retrospectively searched radiology reports for all patients identified with a SAH at a primary and tertiary care university hospital from October 2004 to October 2010. From those, we selected patients admitted to the neurology department with a nontraumatic nonaneurysmal SAH for a review of the CT and/or MRI scans. cSAH was defined as evidence for acute blood in Ն1 adjacent cortical sulci at the convexity of the brain. We excluded patients with concomitant evidence of blood in the basal cisterns, interhemispheric or Sylvian fissures, with intracerebral bleedings that might have ruptured into the subarachnoid space or with damage to the brain parenchyma adjacent to the cSAH. History of trauma was an exclusion criterion. We then reviewed medical records of patients with cSAH and attempted to contact them for clinical follow-up. The study was approved by our hospital's Institutional Review Board and ethics committee.
Data Collection
Medical records were reviewed for demographics, symptoms at presentation, evidence of prior cerebrovascular events, and use of drugs affecting blood clotting. Hypertension, diabetes mellitus, and dyslipidemia were coded as present if they had necessitated medication. Coronary artery disease was defined by a history of myocardial infarction or coronary revascularization. Atrial fibrillation had to be documented by an electrocardiogram.
Follow-up information was obtained by contacting the family physician (nϭ7), telephone interview of the patient and/or next of kin (nϭ11), or by outpatient consultation (nϭ11). Wherever possible, we also extracted information from medical records including imaging and laboratory data that were available at our hospital or from institutions outside our clinic. Patients' outcome at follow-up was graded according to the modified Rankin Scale (mRS) 11 as "favorable" (mRS scores 0 -2) or "unfavorable" (mRS scores 3-6).
Neuroimaging
All patients underwent a brain CT as part of the initial examination procedure at hospital admission. The time lag between onset of clinical symptoms and CT ranged from 2 hours to 10 days (mean, 29Ϯ56 hours), and for 22 patients (92%) it was Յ96 hours. MRI of the brain at 1.5 T was available in 20 of the 24 patients and included axial fluid-attenuated inversion recovery, diffusion-weighted imaging, and gradient echo T2*-weighted sequences (slice thickness 5 mm) 12, 13 for detection of past bleedings or cortical vein thromboses in all patients. The time lag between onset of symptoms and MRI ranged from 6 hours to 16 days (mean, 76Ϯ100 hours). Sixteen patients (80%) underwent MRI within 72 hours after onset of symptoms.
A single expert (C.E.), blinded to clinical data, re-evaluated all MRI scans in a standardized manner, assessing exact location and extent of cSAH and looking for superficial siderosis, old intraparenchymal hemorrhage (Ͼ5 mm), or microbleeds (MBs; Յ5 mm). 12 Following the Boston criteria, multiple hemorrhages or MBs were considered as probable CAA. 14 The presence and number of focal diffusion-weighted imaging abnormalities, old infarcts/lacunes (Յ10 mm), and other morphological abnormalities were recorded. White matter hyperintensities were rated as absent (score 0), punctate (score 1), early confluent (score 2), or confluent (score 3). 15 
Statistical Analysis
Quantitative data are expressed as meanϮ1 SD. Statistical analyses were carried out using SPSS for Windows 2003. Differences between groups and the effect of baseline variables with respect to clinical outcomes were assessed using univariate 2 analyses.
Results
We identified a total of 765 patients who had been diagnosed with SAH (mean age, 56Ϯ16 years) at our institution over the 6-year period. One hundred thirty-one of those patients had a nontraumatic nonaneurysmal SAH and 24 of them fulfilled the imaging criteria of cSAH. Twenty (83%) of these patients were Ͼ60 years old. The detailed demographic and clinical data of this cohort including their medical history is shown in Table 1 .
Clinical Findings
Patients presented with a variety of symptoms as listed in Table 2 . A combination of symptoms was common and occurred in 15 patients. Headaches were altogether noted in 10 patients (42%) with thunderclap headaches suggestive of SAH in 4 subjects and were an isolated finding in 1 patient only. Ten patients (42%) presented with transient acute sensory and/or motor symptoms contralateral to the cSAH. Symptom duration was mostly short, lasting 10 to 20 minutes. Five of these 10 patients had recurrent stereotyped episodes and a gradual spread of sensory disturbances was described by 4 of 7 patients with sensory symptoms. Two patients with sensory symptoms also became transiently aphasic. Similar attacks had not been experienced before by any of our patients. Seizures were experienced by 5 patients. Three patients had recurrent partial seizures with motor signs contralateral to the cSAH generalizing in 1 patient. Two patients presented with generalized seizures. In 3 patients, cSAH was an incidental imaging finding as described subsequently. Dichotomizing patients by age as proposed by Kumar et al 4 ( Figure 1 shows representative imaging findings in a 65-yearold man. CT detected acute cSAH in all subjects. It revealed parenchymal defects from previous cerebrovascular events in 5 patients and showed leukoaraiosis in 15 subjects. There was evidence for cSAH on all MRIs performed. The location and extent of bleeding as shown on MRI is listed in Table 3 . Two patients had a coexisting subcortical intracerebral hemorrhage contralateral to the cSAH, which was asymptomatic in 1 and caused a persistent hemianopsia in the other patient. Five patients showed acute ischemic infarcts on diffusion-weighted imaging distant from the cSAH. These infarcts led to persistent neurological deficits in 2 patients (Figure 2 ) but were clinically asymptomatic in the other 3 patients.
Imaging and Other Diagnostic and Etiologic Findings
MRI provided evidence for previous bleedings in 11 patients. This comprised 10 old intracerebral hemorrhages in 5 patients (which had been clinically apparent in 4) and 111 MBs in 10 patients. The vast majority of MBs (92 of 111) were located cortico-subcortically (Figure 2 ). Pronounced superficial siderosis was noted in 8 patients; 6 of them also had MBs. Old infarcts/lacunes were seen in 2 patients. White matter hyperintensities were present in 16 patients and confluent in 14 (Table 3) . From the distribution of bleedings and additional clinical criteria, probable CAA could be diagnosed in 5 patients and all of them had significant superficial siderosis. 14 Other etiologic causes identified in our cohort were a cerebral hyperperfusion syndrome 7 days after uneventful carotid endarterectomy for the treatment of a high-grade internal carotid artery stenosis and a posterior reversible encephalopathy syndrome.
Intraarterial digital subtraction angiography was obtained in 8 patients including 3 of the 4 patients who did not undergo MRI and was negative in all instances. The time lag between the onset of clinical symptoms to digital subtraction angiography ranged from 7 hours to 14 days (mean, 5Ϯ4.5 days). All remaining patients except 3 underwent noninvasive an- giography (18 time of flight MR angiography, 9 CT angiography), again without identification of a vessel-related cause of bleeding. Transcranial Doppler was performed in all patients and did not show vasospasms in any of them. Surface electroencephalography was done in 14 subjects (58%), but when patients were asymptomatic. Seven of them had transient sensory and/or motor symptoms. Epileptic activity was captured only in the 1 patient with generalized seizures due to a posterior reversible encephalopathy syndrome. The search for potential risk factors of a reversible cerebral vasoconstriction syndrome such as vasoconstrictors or illicit drugs remained negative in all patients.
Follow-Up
No in-hospital mortality occurred. Follow-up data could be obtained in 22 patients after a mean of 33Ϯ19 months (range, 4 -61 months). One patient had emigrated and 1 could not be located.
Clinical outcome was favorable in 8 (36%) and unfavorable in 14 patients (64%). Of the patients with unfavorable outcome, 4 were dependent (mRS 3), 5 were dependent on nursing (mRS 4 to 5), and 5 had died due to extensive ischemic stroke (nϭ1), space-occupying subcortical intracerebral hemorrhage (nϭ1), acute cardiac failure (nϭ1), or pneumonia (nϭ2) in the context of permanent nursing subsequent to stroke (nϭ1) and dementia (nϭ1).
Ischemic stroke during follow-up had occurred in 6 patients (Figure 1) , including 2 of the 5 patients with coincidental ischemic infarcts at cSAH presentation. cSAH did not recur.
There were no clinical factors in our patient cohort that predicted a favorable or unfavorable outcome at follow-up (mRS 0 -2 versus mRS 3-6) except age Ͼ60 years (4 of 8 versus 14 of 14, Pϭ0.003). Imaging features significantly associated with a worse outcome were the presence of MBs (1 of 6 versus 9 of 12, Pϭ0.04) and a white matter hyperintensity score of 2 to 3 (2 of 6 versus 11 of 12, Pϭ0.01). Presence of an old intracerebral hemorrhage (0 of 6 versus 5 of 12, Pϭ0.05) was of borderline significance regarding an unfavorable outcome.
Discussion
Hitherto, convexal nontraumatic SAH has not frequently been considered as a type of nonaneurysmal subarachnoid bleeding, probably also due to obviously quite various presentations and etiologies. Different from Kumar et al, we observed cSAH much more frequently in patients Ͼ60 years than in younger subjects. This could be explained by symptoms that are rather atypical for subarachnoid bleeding in the majority of such patients. In our cohort, almost half of the patients Ͼ60 years (45%) presented with transient ischemic attack mimics, and headaches were lacking in 58%. Thus, this association with cSAH may be easily overlooked or misinterpreted as a secondary phenomenon. This may have played a greater role in Kumar et al's than in our study setting, 4 because we identified patients with cSAH from radiological reports. In this context, it is important to note that CT will also miss a cSAH if it is not performed early after a presumed transient ischemic attack, because blood starts to become isodense within the first few days of subarachnoid bleeding. Albeit, our observation is in line with 2 other reports calling attention to transient ischemic attack-like symptoms as common presentation of cSAH. 5, 6 The basis of transient symptoms in older patients with cSAH is still unclear. Their migratory and often stereotyped nature, their duration, and the lack of electroencephalographic correlate favor the notion of cortical spreading depression 16 possibly triggered by acute subarachnoid blood collections. Aura-like symptoms contralateral to cSAH have also been described by others, 4 -6,17 but none reported electroencephalographic correlates. Indeed, a link between migraine auras and subarachnoid bleeding has been suggested 18 based on the notion that migraine aura symptoms have been related to cortical spreading depression in both conditions. 16 Kumar et al suggested a reversible cerebral vasoconstriction syndrome as a prevailing cause of cSAH in patients Յ60 years. 4 In the 4 patients Յ60 years in our series, 3 presented with thunderclap headaches. Cerebral angiograms, performed in all of them, did not show multiple peripheral narrowing of cerebral arteries typical for reversible cerebral vasoconstric- tion syndrome. However, given the fact that visible arterial narrowing appears to develop preferentially after a few days, 19 it cannot be entirely excluded that angiograms had been performed too early in our study. Risk factors for a reversible cerebral vasoconstriction syndrome like the use of vasoconstrictors or illicit drugs were also not present in our patients.
Beyond 60 years, an increased association of cSAH with CAA has been suggested. 4 Our results strongly support this assumption. We found a large burden of MBs and pronounced superficial siderosis in a substantial number of patients. Evidence from autopsy suggests that subarachnoid bleeding into cerebral sulci may be the primary source of subcortical hematomas in CAA 20 and a high prevalence of superficial siderosis has been demonstrated in patients with histopathologically proven CAA. 21 Apart from frequent evidence for past cerebral bleedings, we also observed a surprisingly high rate of ischemic infarctions associated with (but remote from) cSAH. Although an association of cSAH with ischemic stroke and carotid artery disease has been noted previously, the underlying mechanism(s) of this association remain unclear. 9 In this context, one could consider systemic disturbances such as a sudden rise in blood pressure or a coagulation disorder in the presence of predamaged vessels to account for these coincidental observations, but our data do not support such a speculation.
Our study also provides first data on the prognosis in patients who had experienced a cSAH. In our cohort, cSAH was not recurring but obviously a marker of poor prognosis. After a mean follow-up of 33 months, 64% of patients with a cSAH were rated as having mRS of 3 to 6. Age Ͼ60 years, evidence for previous bleedings, and extensive white matter hyperintensities were significantly associated with increased disability. Of the 5 patients who had died, neurological disease was the (direct or indirect) cause of death in 4. Furthermore, a high rate of subsequent ischemic infarctions and intracerebral bleedings contributed to unfavorable outcomes. This suggests that the occurrence of cSAH, at least in the elderly, probably indicates more advanced damage of the cerebral vasculature. The frequent association with more extensive white matter hyperintensities is in line with this assumption. Whereas recurrent intracerebral hemorrhage has been observed in elderly patients with cSAH also by others, 4, 6, 7, 17 more specifically, recurrent cSAH has not been reported and was also not observed in any of our patients.
Our observations reflect the experience with cSAH in a single tertiary care center, as obtained by a retrospective analysis, and thus may suffer from several sources of bias. These include patient referral and identification and the high proportion of elderly patients with cSAH in our series that must therefore be viewed with some caution. We believe, however, that because of the quite variable and often noncharacteristic presentation of cSAH, especially in individuals Ͼ60 years, the frequency of this condition may have been underestimated before. Another potential weakness of our study comes from the fact that digital subtraction angiography was not performed in all patients. Thus, we cannot completely rule out that other rare causes of cSAH (like a small low-flow arteriovenous fistula or malformation) may have escaped detection. In the absence of recurrence of cSAH and given that isolated cSAH (in the absence of parenchymal involvement) has rarely been documented as a manifestation of ruptured arteriovenous malformations, 22 the likelihood for this appears low. Finally, prospective and more comprehensive data collection will be needed to clarify the observed In addition, DWI MRI reveals an acute ischemic infarct in the left cerebellum (arrows) with restricted diffusion on ADC (right image). B, CT (inset) of a 68-year-old patient showing a cSAH in the right posterior frontal lobe and diffusely hypodense white matter. Gradient echo T2* MRI suggests cerebral amyloid angiopathy by presence of cortico-subcortical microbleeds (arrow), meningeal hemosiderosis (dotted arrows), and extensive white matter changes ipsilateral to the cSAH. cSAH indicates convexal subarachnoid hemorrhage; DWI, diffusion-weighted imaging; ADC, apparent diffusion coefficient.
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